Open Access

Lp(a) as target in cardiovascular prevention: Why worry and how to assess?

Topic: Lipids
Organised by PACE-CME, supported by Novartis and Sanofi in the form of an educational grant

Congress Presentation

About the speaker

Doctor Pia Kamstrup

Copenhagen University Hospital - Herlev Gentofte, Herlev (Denmark)
3 presentations
0 follower

4 more presentations in this session

Lp(a): The new kid in lipid management

Speaker: Professor E. Stroes (Amsterdam, NL)

Thumbnail

Novel strategies to lower Lp(a) What are the emerging insights & therapies?

Speaker: Professor S. Tsimikas (San Diego, US)

Thumbnail

ASCVD risk reduction for patients with high Lp(a) in 2020: is there a role for PCSK9 inhibition?

Speaker: Professor V. Bittner (Birmingham, US)

Thumbnail

Discussion.

Speaker: Professor E. Stroes (Amsterdam, NL)

Thumbnail

Access the full session

Lp(a), a new lipid frontier in CV risk management & target for therapy

Speakers: Doctor P. Kamstrup, Professor E. Stroes, Professor S. Tsimikas, Professor V. Bittner, Professor E. Stroes
Thumbnail

About the event

Image

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk